Den europeiske union - estisk - EMA (European Medicines Agency)

astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - vaktsiinid - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.

Den europeiske union - estisk - EMA (European Medicines Agency)

sanofi winthrop industrie - aspartinsuliin - diabeet mellitus - diabeetis kasutatavad ravimid - truvelog mix 30 is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 10 years and above.

Den europeiske union - estisk - EMA (European Medicines Agency)

pfizer europe ma eeig - somatrogon - growth and development - hÜpofÜÜsi ja hÜpotaalamuse hormoonid ja nende analoogid - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.

Den europeiske union - estisk - EMA (European Medicines Agency)

novartis europharm limited - ranibizumab - wet macular degeneration; macular edema; diabetes complications; myopia, degenerative; choroidal neovascularization - oftalmoloogilised vahendid - lucentis on näidustatud täiskasvanute jaoks:ravi neovascular (märg) vanusega seotud makuladegeneratsiooni (amd)raviks nägemispuudega tõttu choroidal neovascularisation (cnv)ravi nägemispuudega tõttu diabeediga macular turse (dme)ravi nägemispuudega tõttu macular turse teisejärguline võrkkesta veeni oklusioon (branch rvo-või kesk-rvo).

Den europeiske union - estisk - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - talidomiid - mitu müeloomit - immunosupressandid - thalidomide bms in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged >/= 65 years or ineligible for high dose chemotherapy. thalidomide bms is prescribed and dispensed according to the thalidomide celgene pregnancy prevention programme (see section 4.

Estland - estisk - Ravimiamet

teva b.v. - mükofenoolhape - gastroresistentne tablett - 180mg 250tk; 180mg 100tk; 180mg 20tk; 180mg 50tk

Estland - estisk - Ravimiamet

teva b.v. - mükofenoolhape - gastroresistentne tablett - 360mg 50tk; 360mg 120tk; 360mg 250tk

Den europeiske union - estisk - EMA (European Medicines Agency)

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmoloogilised vahendid - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Den europeiske union - estisk - EMA (European Medicines Agency)

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmoloogilised vahendid - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Den europeiske union - estisk - EMA (European Medicines Agency)

lipomed gmbh - talidomiid - mitu müeloomit - immunosupressandid - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.